Wegovy, Ozempic

After easing diabetes and weight loss journey for many, the popular medications Ozempic and Wegovy have shown fresh promise ...
More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...
Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.
Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...
It's something Downey says he has struggled with for years — addiction to both food and alcohol. The 39-year-old says he's sober now, and he believes Wegovy is helping him stay that way.